Abstract
Background Environmental exposure to metal mixtures is common and may be associated with increased risk for neurodegenerative disorders including Alzheimer’s disease
Objective This study examined associations of mixed metal exposures with medial temporal lobe (MTL) MRI structural metrics and neuropsychological performance.
Methods Metal exposure history, whole blood metal, and neuropsychological tests were obtained from subjects with/without a history of mixed metal exposure from welding fumes (42 exposed subjects; 31 controls). MTL structures (hippocampus, entorhinal and parahippocampal cortices) were assessed by morphologic (volume, cortical thickness) and diffusion tensor imaging [mean (MD), axial (AD), radial diffusivity (RD), and fractional anisotropy (FA)] metrics. In exposed subjects, correlation, multiple linear, Bayesian kernel machine regression, and mediation analyses were employed to examine effects of single- or mixed-metal predictor(s) and their interactions on MTL structural and neuropsychological metrics; and on the path from metal exposure to neuropsychological consequences.
Results Compared to controls, exposed subjects had higher blood Cu, Fe, K, Mn, Pb, Se, and Zn levels (p’s<0.026) and poorer performance in processing/psychomotor speed, executive, and visuospatial domains (p’s<0.046). Exposed subjects displayed higher MD, AD, and RD in all MTL ROIs (p’s<0.040) and lower FA in entorhinal and parahippocampal cortices (p’s<0.033), but not morphological differences. Long-term mixed-metal exposure history indirectly predicted lower processing speed performance via lower parahippocampal FA (p=0.023). Higher whole blood Mn and Cu predicted higher entorhinal diffusivity (p’s<0.043) and lower Delayed Story Recall performance (p=0.007) without overall metal mixture or interaction effects.
Discussion Mixed metal exposure predicted MTL structural and neuropsychological features that are similar to Alzheimer’s disease at-risk populations. These data warrant follow-up as they may illuminate the path for environmental exposure to Alzheimer’s disease-related health outcomes.
Highlights
Mixed metal exposed subjects through welding fumes had higher blood Cu, Fe, K, Mn, Pb, Se, and Zn levels than controls.
Exposed subjects had higher diffusion tensor imaging (DTI) mean (MD), axial (AD), radial (RD) diffusivity values in all medial temporal lobe (MTL) regions of interest (ROI) (hippocampus, entorhinal and parahippocampal cortices) and lower fractional anisotropy (FA) in the entorhinal and parahippocampal cortices without significant morphologic differences.
Long-term mixed metal exposure history predicted altered MTL DTI metrics (lower parahippocampal FA and higher hippocampal RD).
Across correlation, multiple linear, and Bayesian kernel machine regression analyses, higher whole blood Mn and Cu levels predicted higher entorhinal diffusivity values and lower Delayed Story Recall performance, features resembling Alzheimer’s disease at-risk populations.
MTL DTI metrics mediate, at least partially, the effects of metal exposure on cognitive performance.
Competing Interest Statement
The authors have declared no competing interest.
Funding Statement
This work was supported by NIH grants R01 ES019672, R01 NS060722, U01s NS082151 and NS112008, the Hershey Medical Center General Clinical Research Center (National Center for Research Resources, UL1 TR002014), the Penn State College of Medicine Translational Brain Research Center, the PA Department of Health Tobacco CURE Funds, the National Research Foundation of Korea (2019R1G1A109957511; RS-2023-00247689), and Dong-A University Research Fund.
Author Declarations
I confirm all relevant ethical guidelines have been followed, and any necessary IRB and/or ethics committee approvals have been obtained.
Yes
The details of the IRB/oversight body that provided approval or exemption for the research described are given below:
The Internal Review Board (IRB) of Penn State Hershey gave ethical approval for this work.
I confirm that all necessary patient/participant consent has been obtained and the appropriate institutional forms have been archived, and that any patient/participant/sample identifiers included were not known to anyone (e.g., hospital staff, patients or participants themselves) outside the research group so cannot be used to identify individuals.
Yes
I understand that all clinical trials and any other prospective interventional studies must be registered with an ICMJE-approved registry, such as ClinicalTrials.gov. I confirm that any such study reported in the manuscript has been registered and the trial registration ID is provided (note: if posting a prospective study registered retrospectively, please provide a statement in the trial ID field explaining why the study was not registered in advance).
Yes
I have followed all appropriate research reporting guidelines, such as any relevant EQUATOR Network research reporting checklist(s) and other pertinent material, if applicable.
Yes
Footnotes
The background and interpretation have been revised, and new data analyses added.
Data Availability
All data produced in the present study are available upon reasonable request to the authors.
